Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: Subgroup analysis from the IMPROVE study

Current Medical Research and Opinion

Volumn 25, Issue 11, 2009, Pages 2643-2654

  Wenying, Yang ^a   Benroubi, Marian ^b   Borzi, Vito ^c   Gumprecht, Janusz ^d   Kawamori, Ryuzo ^e   Shaban, Joseph ^f   Shah, Siddharth ^g   Shestakova, Marina ^h   Ligthelm, Robert ⁱ   Valensi, Paul ^j  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b KAT HOSPITAL   (Greece)

^c UNIVERSITY OF CATANIA   (Italy)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

^e JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f WINDSOR REGIONAL HOSPITAL   (Canada)

^g Bhatia Hospital   (India)

^h N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

ⁱ EHM Clinic   (Netherlands)

^j UNIVERSITÉ PARIS 13   (France)

more..

Author keywords

Biphasic insulin aspart; Observational study; Premixed insulin formulation; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN ASPART; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PATIENT SATISFACTION; SIDE EFFECT; WEIGHT GAIN; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ADULT; AGED; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 72549104985     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903276745     Document Type: Article

References (21)

1. Leahy JL. Pathogenesis of type 2 diabetes mellitus. Arch Med Res 2005;36:197-209
2. Bell DS. Importance of postprandial glucose control. South Med J 2001;94:804-809
3. Coates PA, Ollerton RL, Owens DR, et al. A glimpse of 'natural history' of established type 2 (non-insulin dependent) diabetes mellitus from the spectrum of metabolic and hormonal responses to a mixed meal at the time of diagnosis. Diabetes Res Clin Pract 1994;26:177-187
4. Polonsky KS, Sturis J, Bell GI. Non-insulin dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 1996;334:777-783 (Pubitemid 26089361)
5. Polonsky KS, Given BD, Hirsch LJ, et al. Abnormal patterns of insulin secretion in non-insulin dependent diabetes mellitus. N Engl J Med 1998;318:1231-1239
6. Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-412 (Pubitemid 30609442)
7. UK Prospective Diabetes Study Group. Intensive blood-glucose control with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853
8. International Diabetes Federation. Guidelines task force, Brussels, 2005
9. Rodbard HW, Blonde L, Braithwaite SS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007;13(Suppl 1):1-68
10. Garber AJ, Ligthelm R, Christiansen JS, Liebl A. Premixed insulin treatment for type 2 diabetes: analogue or human? Diabetes Obes Metab 2007;9:630-639
11. Sharma SK, Al-Mustafa M, Oh SJ, et al. Biphasic insulin aspart 30 treatment in patients with type 2 diabetes poorly controlled on prior diabetes treatment: results from the PRESENT study. Curr Med Res Opin 2008;24:645-652
12. Raskin P, Allen E, Hollander P, et al. Initiating insulin therapy in type 2 diabetes. Diabetes Care 2005;28:260-265
13. Kann PH, Wascher T, Zackova V, et al. Starting insulin therapy in type 2 diabetes: twice-daily biphasic insulin aspart 30 plus metformin versus oncedaily insulin glargine plus glimepiride. Exp Clin Endocrinol Diabetes 2006;114:527-532 (Pubitemid 44870902)
14. Ligthelm RJ, Borzi V, Gumprecht J, et al. Importance of observational studies in clinical practice. Clin Ther 2007;29:1284-1292 (Pubitemid 351181208)
15. Concato J. Observational versus experimental studies: what's the evidence for a hierarchy? NeuroRx 2004;1:341-347
16. Valensi P, Benroubi M, Borzi V, et al., on behalf of the IMPROVE Study Group Expert Panel. The IMPROVE study - a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts. Int J Clin Pract 2008;62:1809-1819
17. Brod M, Skovlund SE, Wittrup-Jensen KU. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res 2006;15:481-491
18. Bodmer M, Meier C, Krähenbühl S, et al. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes Care 2008;31:2086-2091
19. Bebakar WMW, Chow CC, Kadir KA, et al. Adding biphasic insulin aspart 30 once or twice daily is more efficacious than optimizing oral antidiabetic treatment in patients with type 2 diabetes. Diabetes Obes Metab 2007;9:724-732
20. Boehm BO, Vaz JA, Brøndsted L, et al. Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes. Eur J Intern Med 2004;15:496-502 (Pubitemid 40164478)
21. Valensi P, Benroubi M, Borzi V, et al, IMPROVE Study Group Expert Panel. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study. Int J Clin Pract 2009 Mar;63:522-531